Position in ZTS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$993,033
-$1,038,051 QoQ
Shares Held
13,819
-19.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#641
of 1,408 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $122,719,355 across 16 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,409,759 | $112,400,085 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
77,986 | $2,642,165 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
55,602 | $1,368,365 | |
| 4 | VTRS |
Viatris Inc
|
75,955 | $1,206,165 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
13,819 | $993,033 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
40,725 | $652,821 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
3,295 | $555,339 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
32,404 | $469,533 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $993,033 | 13,819 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,031,084 | 17,182 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,937,376 | 15,398 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $3,049,308 | 20,840 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $3,735,085 | 22,685 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,071,492 | 12,714 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,341,433 | 11,984 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,936,951 | 11,173 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,634,060 | 9,657 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,921,791 | 9,737 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $1,661,682 | 9,551 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,996,454 | 17,400 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,454,019 | 8,736 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $1,119,642 | 7,640 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $1,102,536 | 7,435 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,240,186 | 7,215 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $1,458,555 | 7,734 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $1,956,876 | 8,019 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,396,643 | 7,194 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $921,550 | 4,945 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $771,022 | 4,896 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $646,112 | 3,904 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $614,514 | 3,716 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,174,295 | 8,569 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $866,198 | 7,360 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||